Neurallys

Curated by Signal

Developing a device for the treatment of Hydrocephalus

Overview

Neurallys is developing a device for the treatment of Hydrocephalus (caused by an accumulation of cerebrospinal fluid within the brain resulting in abnormal intracranial pressure). It is an intelligent sensor, which continuously measures intracranial pressure in hydrocephalus patients who have an implanted shunt system. It helps detect valve malfunctions and thereby avoid exploratory surgical intervention.

Key facts

Founded: 2016
Headquarters: Paris, France
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Panaxium
Developer of medical equipment for surgeons and neurologists to treat brain injuries
Life Sciences TechnologyAix-en-Provence, France
MyStar Sanofi
Provider of devices to help manage diabetes
Life Sciences TechnologyParis, France
C.C.D. International
Design, development, and manufacturing of single use medical devices for assisted reproduction, and obstetrics and gynaecology.
Life Sciences TechnologyParis, France

About Neurallys

What does Neurallys do?

Neurallys is developing a device for the treatment of Hydrocephalus (caused by an accumulation of cerebrospinal fluid within the brain resulting in abnormal intracranial pressure).

Where is Neurallys headquartered?

Neurallys is headquartered in Paris, France.

When was Neurallys founded?

Neurallys was founded in 2016.

Which sector is Neurallys in?

Neurallys operates in Life Sciences Technology.

Who are Neurallys's competitors?

Companies similar to Neurallys include Panaxium, MyStar Sanofi, and C.C.D. International.